Tetraphase Pharmaceuticals, Inc.
(NASDAQ : TTPH)

( )
TTPH After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 3.71%45.020.0%$295.73m
GWPHGW Pharmaceuticals Plc -0.10%214.726.1%$259.81m
VRXValeant Pharmaceuticals International, Inc. 0.36%33.0914.1%$194.71m
BHCBausch Health Cos., Inc. 0.36%33.090.0%$177.02m
HZNPHorizon Therapeutics Plc -2.12%86.775.5%$175.60m
JAZZJazz Pharmaceuticals Plc -2.03%161.412.3%$148.59m
ICLRICON plc 0.22%180.224.2%$134.70m
CTLTCatalent, Inc. -2.78%101.642.1%$101.71m
PRGOPerrigo Co. Plc 1.78%41.776.9%$85.75m
ARGXargenx SE 2.09%295.790.0%$59.45m
TNXPTonix Pharmaceuticals Holding Corp. 0.00%1.020.2%$52.97m
UTHRUnited Therapeutics Corp. -2.59%160.0914.1%$47.98m
AMRNAmarin Corp. Plc -3.34%5.791.5%$36.94m
ZYNEZynerba Pharmaceuticals, Inc. -0.24%4.146.0%$36.93m
SAGESAGE Therapeutics, Inc. -2.70%74.907.6%$35.44m

Company Profile

Capitalizing on breakthrough synthetic chemistry, Tetraphase Pharmaceuticals is leveraging a dynamic drug engine targeted at several significant disease categories.